$0.563
-0.011 (-1.92%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
KTTA Prediction & Forecast by Similar Chart Analysis
Alphio's KTTA stock price prediction model matches the current Pasithea Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.56 (-1.35%). The 1-week path is $0.58 (+2.78%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Pasithea Therapeutics Corp Stock?
Pasithea Therapeutics Corp (KTTA) appears to be a good buy right now due to its recent positive news and technical indicators. The stock is currently priced at $0.56, with a 5-day change of +3.82% and a 20-day change of +21.77%. The RSI is at 65.184, indicating strong momentum. Additionally, the company received FDA Orphan Drug Designation for its lead candidate, PAS-004, which could enhance its market position and attract investor interest. However, the main risk is the negative earnings trend, with a net income loss of $10,110,868 in Q4 2025, which investors should monitor closely.
KTTA stock price ended at $0.56 on Tuesday, after losing -1.92%
Pasithea Therapeutics Corp (KTTA) last closed at $0.563, losing -1.92%. These facts feed the 1-day and 1-week KTTA price prediction above.
Forecast Drivers
Pasithea Therapeutics Corp (KTTA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches KTTA, ranked by similarity.
Seasonality analysis for KTTA
Historically the probability of a positive September return for KTTA is 0.00%. April offers the highest probability of a positive month at 7.81%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for KTTA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $0.71 | $0.87 | $0.98 | +54.21% |
| Oct 2026 | $0.58 | $0.64 | $0.77 | +13.98% |
| Nov 2026 | $0.61 | $0.74 | $0.75 | +31.37% |
| Dec 2026 | $0.78 | $0.83 | $0.95 | +47.00% |
In 2026, Pasithea Therapeutics Corp (KTTA) is projected to range from $0.58 to $0.98.
Pasithea Therapeutics Corp 2026 monthly forecast
In Sep 2026, Pasithea Therapeutics Corp is projected to average $0.87, with a low of $0.71 and high of $0.98.
In Oct 2026, Pasithea Therapeutics Corp is projected to average $0.64, with a low of $0.58 and high of $0.77.
In Nov 2026, Pasithea Therapeutics Corp is projected to average $0.74, with a low of $0.61 and high of $0.75.
In Dec 2026, Pasithea Therapeutics Corp is projected to average $0.83, with a low of $0.78 and high of $0.95.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.